Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
Free Cash Flow
Cyclopharm Ltd
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Cyclopharm Ltd
ASX:CYC
|
Free Cash Flow
-AU$7.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
Neurotech International Ltd
ASX:NTI
|
Free Cash Flow
-AU$6.3m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Free Cash Flow
-AU$17.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-12%
|
|
Cochlear Ltd
ASX:COH
|
Free Cash Flow
AU$334.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
23%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Free Cash Flow
-AU$5.6m
|
CAGR 3-Years
-112%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-23%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Free Cash Flow
AU$646.9k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Free Cash Flow?
Free Cash Flow
-7.7m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Free Cash Flow amounts to -7.7m AUD.
What is Cyclopharm Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-32%
Over the last year, the Free Cash Flow growth was 6%. The average annual Free Cash Flow growth rates for Cyclopharm Ltd have been 7% over the past three years , -32% over the past five years .